3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
8
Meningioma
2
Glioblastoma
2
Sarcoma, Synovial
1
Recurrence
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Medulloblastoma
1
Glioma
1
Extensive Stage Small Cell Lung Cancer
1
Esthesioneuroblastoma, Olfactory
1
Ependymoma
1
Disease Progression
1
Carcinoid Tumor
1
Advanced Lung Neuroendocrine Tumor
1
Adrenal Gland Neoplasms
1
Adrenal Cortex Neoplasms
1
Adenoma, Islet Cell
1
Interventions
fludarabine
3
aldesleukin
3
Specimen Handling
3
Cyclophosphamide
3
Sunitinib
2
Fluorouracil
2
Bevacizumab
2
trastuzumab deruxtecan
1
sodium propionate
1
semaglutide
1
repotrectinib
1
patritumab deruxtecan
1
isosorbide-5-mononitrate
1
fludarabine phosphate
1
dehydroftorafur
1
Ultrasonography
1
Tretinoin
1
Tomography, X-Ray Computed
1
Surveys and Questionnaires
1
Radiosurgery
1
Psilocybin
1
Positron-Emission Tomography
1
Photography
1
Pemetrexed
1
Oxaliplatin
1
Oviposition
1
Memantine
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Leucovorin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
lutetium Lu 177 dotatate
×
30 days
×
Clear all
No trials found.